Business Context and Reporting Period
Company: Kewaunee Scientific Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended July 31, 2011
Business Overview: The Company manufactures laboratory furniture and equipment. Operations are segmented into Domestic and International divisions. The Company is classified as a smaller reporting company.
Key Financial Metrics
| Metric (in thousands) | Q1 2012 (Ended July 31, 2011) | Q1 2011 (Ended July 31, 2010) |
|---|---|---|
| Net Sales | $26,321 | $24,858 |
| Gross Profit | $4,188 | $4,999 |
| Gross Margin | 15.9% | 20.1% |
| Operating Earnings | $233 | $1,098 |
| Net Earnings (Total) | $108 | $724 |
| Net Earnings Attributable to Kewaunee | $22 | $657 |
| Diluted EPS (Attributable to Kewaunee) | $0.01 | $0.25 |
| Cash and Cash Equivalents | $2,652 | $1,812 |
| Short-term Borrowings | $8,672 | $6,588 |
| Working Capital | $22,071 | $22,115 |
| Order Backlog | $69.7 million | $66.9 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 5.9% to $26.3 million, driven primarily by a 11.7% increase in Domestic Operations ($23.4 million) due to demand for larger laboratory projects. International Operations declined 25.2% to $2.9 million due to construction delays on a large project.
- Margin Compression: Gross profit margin decreased from 20.1% to 15.9%. Management attributed this to lower selling prices in a competitive marketplace and higher raw material costs, specifically steel and epoxy resin.
- Profitability Decline: Operating earnings dropped 78.8% to $233,000. Net earnings attributable to Kewaunee Scientific Corporation fell 96.7% to $22,000. This sharp decline was exacerbated by a significant increase in noncontrolling interest allocations ($86,000 vs. $67,000) and higher interest expense ($95,000 vs. $45,000) related to facility expansion debt.
- Cash Flow: Operating activities used $887,000 in cash, compared to $88,000 used in the prior year. This was driven by a $1.3 million decrease in accounts payable and a $907,000 increase in prepaid assets, offsetting earnings.
- Liquidity: Short-term borrowings increased by $2.1 million to $8.7 million to fund operations. The current ratio remained stable at 2.0-to-1.0.
Guidance, Outlook, and Risks
- Outlook: Management expects sales for fiscal year 2012 to improve over fiscal year 2011 and anticipates profitability for the full year. This is based on the current order backlog, cost-saving initiatives, and new product sales.
- Subsequent Event: In August 2011, the Company amended its credit facility to increase the line of credit to $15 million, extend the maturity to July 31, 2014, and raise the maximum debt-to-worth ratio to 1.25-to-1.00.
- Risks and Contingencies:
- Market Dependency: Demand is heavily dependent on the number of laboratory construction projects and the progress of projects already under construction.
- Supply Chain & Pricing: Volatility in raw material prices (steel, epoxy) and competitive pricing pressures impact margins.
- Customer Behavior: Changes in product designs or delivery dates by customers can delay manufacturing and revenue recognition.
Investor Verification Checklist
- Margin Sustainability: Verify if the 15.9% gross margin is a temporary anomaly due to specific project mix or a structural shift due to raw material costs.
- International Recovery: Monitor the status of the delayed international project cited as the cause for the 25% revenue drop in that segment.
- Debt Utilization: Confirm the utilization rate of the newly expanded $15 million credit facility and the impact of increased interest expense on future earnings.
- Noncontrolling Interest Impact: Assess the volatility of net earnings attributable to shareholders given the significant portion of earnings allocated to noncontrolling interests ($86k vs $22k net to Kewaunee).
- Backlog Conversion: Track the conversion rate of the $69.7 million order backlog into recognized revenue to validate the "improvement" guidance for FY2012.